08:43 EDT MediWound (MDWD) down 8% at $16.50 following offering
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDWD:
- MediWound announces marketing approval of NexoBrid in Australia
- MediWound’s Earnings Call: Progress Amid Challenges
- MediWound Executives Purchase Shares, Signaling Confidence
- Promising Developments and Financial Stability Drive Buy Rating for MediWound
- Promising Developments and Strong Demand Drive Buy Rating for MediWound
